iCAD INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-10-06: Reporting owner SUSSMAN ELLIOT J MD MBA; Form 4; Security Director Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-09-29: Reporting owner Subramaniam Somu; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-09-29: Reporting owner RAPPAPORT STEVEN N; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-09-29: Reporting owner Goodman Robert L; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-10-06 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,303 0 owned after | $2.00 exercise price | 2017-10-11 | |
| 2017-09-29 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,538 4,538 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-09-29 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,958 6,958 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-09-29 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,235 4,235 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-09-29 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,143 5,143 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-09-29 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,470 8,470 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-09-29 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,958 6,958 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-09-29 | Ecock Anthony F Director | 4 | Direct Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,050 6,050 owned after | $4.42 exercise price | 2017-10-04 | |
| 2017-07-13 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.00 exercise price | 2017-09-22 | |
| 2017-06-30 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,286 7,286 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-06-30 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,019 6,019 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-06-30 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,286 7,286 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-06-30 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,869 8,869 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-06-30 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,435 4,435 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-06-30 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,335 6,335 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-06-30 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,385 5,385 owned after | $4.19 exercise price | 2017-07-05 | |
| 2017-04-07 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.25 exercise price | 2017-04-25 | |
| 2017-04-07 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.00 exercise price | 2017-04-25 | |
| 2017-04-07 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 0 owned after | $2.15 exercise price | 2017-04-25 | |
| 2017-04-07 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.00 exercise price | 2017-04-25 | |
| 2017-04-07 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.00 exercise price | 2017-04-25 | |
| 2017-04-04 | Brem Rachel Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.25 exercise price | 2017-04-06 | |
| 2017-03-31 | HOWARD DR LAWRENCE Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,098 7,098 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-31 | Brem Rachel Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,309 4,309 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-31 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,830 5,830 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-31 | SUSSMAN ELLIOT J MD MBA Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,830 5,830 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-31 | Goodman Robert L Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,549 3,549 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-31 | Ecock Anthony F Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,070 5,070 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-31 | Subramaniam Somu Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,816 4,816 owned after | $4.81 exercise price | 2017-04-04 | |
| 2017-03-30 | Ecock Anthony F Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.25 exercise price | 2017-03-31 | |
| 2017-03-27 | SUSSMAN ELLIOT J MD MBA Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,977 0 owned after | $2.25 exercise price | 2017-03-29 | |
| 2017-01-17 | SUSSMAN ELLIOT J MD MBA Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $2.80 exercise price | 2017-01-19 |